{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T20:25:10Z","timestamp":1786911910086,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100017542","name":"Beijing Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Research & Clinical Practice"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.orcp.2026.06.005","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T20:42:24Z","timestamp":1781901744000},"page":"327-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interpretable machine learning and incremental prognostic model for all-cause and cardiovascular mortality in obesity with MASLD population: Comorbidity insights from triglyceride-glucose and its obesity-related derivatives"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7647-9255","authenticated-orcid":false,"given":"Limin","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.orcp.2026.06.005_bib1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.orcp.2026.06.005_bib2","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.orcp.2026.06.005_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.orcp.2026.06.005_bib4","doi-asserted-by":"crossref","DOI":"10.20945\/2359-4292-2022-0138","article-title":"Histological findings and NAFLD\/NASH Status in liver biopsies of patients subjected to bariatric surgery","volume":"68","author":"Malucelli","year":"2023","journal-title":"Arch Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.orcp.2026.06.005_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41572-025-00599-1","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults","volume":"11","author":"Huang","year":"2025","journal-title":"Nat Rev Dis Prim"},{"issue":"5","key":"10.1016\/j.orcp.2026.06.005_bib6","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.orcp.2026.06.005_bib7","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"issue":"10046","key":"10.1016\/j.orcp.2026.06.005_bib8","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0140-6736(16)30175-1","article-title":"Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents","volume":"388","author":"Global","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.orcp.2026.06.005_bib9","article-title":"Triglyceride glucose index: A new biomarker in predicting cardiovascular risk","volume":"29","author":"Araujo","year":"2022","journal-title":"Prev Med Rep"},{"issue":"1","key":"10.1016\/j.orcp.2026.06.005_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-66692-9","article-title":"Superiority of the triglyceride glucose index over the homeostasis model in predicting metabolic syndrome based on NHANES data analysis","volume":"14","author":"Wan","year":"2024","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.orcp.2026.06.005_bib11","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1210\/jc.2010-0288","article-title":"The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp","volume":"95","author":"Guerrero-Romero","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.orcp.2026.06.005_bib12","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12876-025-03888-x","article-title":"Triglyceride glucose waist circumference and non alcoholic fatty liver disease: a systematic review and meta analysis","volume":"25","author":"Xin","year":"2025","journal-title":"BMC Gastroenterol"},{"issue":"8","key":"10.1016\/j.orcp.2026.06.005_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0324483","article-title":"Association of triglyceride glucose-body mass index (TyG-BMI) with metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis","volume":"20","author":"Boushehri","year":"2025","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.orcp.2026.06.005_bib14","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.1038\/s41598-025-88478-3","article-title":"Association between TyG-related parameters and NAFLD risk in Japanese non-obese population","volume":"15","author":"Wang","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.orcp.2026.06.005_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2025.105813","article-title":"Effects of the triglyceride-glucose index on non-alcoholic fatty liver disease: Causal evidence from longitudinal cohort studies","volume":"133","author":"Cao","year":"2025","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"10.1016\/j.orcp.2026.06.005_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12933-024-02572-w","article-title":"Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK Biobank","volume":"24","author":"Qiao","year":"2025","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.orcp.2026.06.005_bib17","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12933-024-02287-y","article-title":"Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease","volume":"23","author":"Min","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.orcp.2026.06.005_bib18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12933-024-02354-4","article-title":"Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999-2018","volume":"23","author":"Zhang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.orcp.2026.06.005_bib19","unstructured":"World Health Organization: Obesity and overweight. \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight\u3009; 2024."},{"issue":"1","key":"10.1016\/j.orcp.2026.06.005_bib20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.orcp.2026.06.005_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12933-022-01483-y","article-title":"The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study","volume":"21","author":"Park","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.orcp.2026.06.005_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12933-022-01725-z","article-title":"The associations between changes in hepatic steatosis and heart failure and mortality: a nationwide cohort study","volume":"21","author":"Park","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.orcp.2026.06.005_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/apt.13012","article-title":"Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey","volume":"41","author":"Ruhl","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.orcp.2026.06.005_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"10.1016\/j.orcp.2026.06.005_bib25","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/hepr.12647","article-title":"Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: A meta-analysis study","volume":"46","author":"Sun","year":"2016","journal-title":"Hepatol Res"},{"issue":"10","key":"10.1016\/j.orcp.2026.06.005_bib26","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.orcp.2026.06.005_bib27","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ajcn\/88.2.324","article-title":"The US Department of Agriculture Automated Multiple-Pass Method reduces bias in the collection of energy intakes","volume":"88","author":"Moshfegh","year":"2008","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.orcp.2026.06.005_bib28","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.orcp.2026.06.005_bib29","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.orcp.2026.06.005_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12933-023-02113-x","article-title":"The triglyceride-glucose index: a novel predictor of stroke and all-cause mortality in liver transplantation recipients","volume":"23","author":"Ding","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.orcp.2026.06.005_bib31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12933-022-01664-9","article-title":"Association between triglyceride glucose index and risk of cerebrovascular disease: systematic review and meta-analysis","volume":"21","author":"Yan","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.orcp.2026.06.005_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212963","article-title":"Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: An analysis of the 2007-2010 Korean National Health and Nutrition Examination Survey","volume":"14","author":"Lim","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.orcp.2026.06.005_bib33","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12967-016-1020-8","article-title":"Triglyceride glucose-waist circumference, a novel and effective predictor of diabetes in first-degree relatives of type 2 diabetes patients: cross-sectional and prospective cohort study","volume":"14","author":"Zheng","year":"2016","journal-title":"J Transl Med"},{"issue":"3","key":"10.1016\/j.orcp.2026.06.005_bib34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1467-789X.2011.00952.x","article-title":"Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis","volume":"13","author":"Ashwell","year":"2012","journal-title":"Obes Rev"},{"issue":"4","key":"10.1016\/j.orcp.2026.06.005_bib35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/met.2008.0034","article-title":"The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects","volume":"6","author":"Simental-Mendia","year":"2008","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.orcp.2026.06.005_bib36","unstructured":"Public-Use Linked Mortality Files. \u3008https:\/\/www.cdc.gov\/nchs\/data-linkage\/mortality-public.htm\u3009; 2019."},{"issue":"1","key":"10.1016\/j.orcp.2026.06.005_bib37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/jssam\/smz061","article-title":"Corrigendum to: Who Can You Count On? Understanding the Determinants of Reliability","volume":"9","author":"Tourangeau","year":"2021","journal-title":"J Surv Stat Methodol"},{"issue":"12","key":"10.1016\/j.orcp.2026.06.005_bib38","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jama.2020.14545","article-title":"Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000\u20132017-2018","volume":"324","author":"Muntner","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.orcp.2026.06.005_bib39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12933-024-02343-7","article-title":"Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease","volume":"23","author":"Chen","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.orcp.2026.06.005_bib40","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12933-025-02758-w","article-title":"The association between different insulin resistance surrogates and all-cause mortality and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease","volume":"24","author":"Gao","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.orcp.2026.06.005_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1422686","article-title":"Advances in pathogenesis and treatment of vascular endothelial injury-related diseases mediated by mitochondrial abnormality","volume":"15","author":"Pang","year":"2024","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.orcp.2026.06.005_bib42","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10456-024-09938-4","article-title":"Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: focus on mitochondrial dysfunction","volume":"27","author":"Pang","year":"2024","journal-title":"Angiogenesis"},{"issue":"1","key":"10.1016\/j.orcp.2026.06.005_bib43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12933-024-02215-0","article-title":"Association between triglyceride-glucose related indices with the all-cause and cause-specific mortality among the population with metabolic syndrome","volume":"23","author":"Wei","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.orcp.2026.06.005_bib44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12933-025-02591-1","article-title":"The triglyceride-glucose index and its obesity-related derivatives as predictors of all-cause and cardiovascular mortality in hypertensive patients: insights from NHANES data with machine learning analysis","volume":"24","author":"Li","year":"2025","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.orcp.2026.06.005_bib45","first-page":"223","article-title":"Quadruple Decision Making for Parkinson's Disease Patients: Combining Expert Opinion, Patient Preferences, Scientific Evidence, and Big Data Approaches to Reach Precision Medicine","volume":"10","author":"van den Heuvel","year":"2020","journal-title":"J Park Dis"},{"key":"10.1016\/j.orcp.2026.06.005_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101934","article-title":"Development and validation of an insulin resistance model for a population without diabetes mellitus and its clinical implication: a prospective cohort study","volume":"58","author":"Tsai","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.orcp.2026.06.005_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103470","article-title":"Machine learning and SHAP value interpretation for predicting comorbidity of cardiovascular disease and cancer with dietary antioxidants","volume":"79","author":"Qi","year":"2025","journal-title":"Redox Biol"},{"key":"10.1016\/j.orcp.2026.06.005_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2025.180003","article-title":"Assessing the effect of perfluoroalkyl and polyfluoroalkyl substances on cardiovascular-kidney-metabolic syndrome: Insights from an interpretable machine learning model","volume":"993","author":"Zheng","year":"2025","journal-title":"Sci Total Environ"}],"container-title":["Obesity Research & Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871403X26000657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871403X26000657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T19:33:58Z","timestamp":1786908838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871403X26000657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1871403X26000657"],"URL":"https:\/\/doi.org\/10.1016\/j.orcp.2026.06.005","relation":{},"ISSN":["1871-403X"],"issn-type":[{"value":"1871-403X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interpretable machine learning and incremental prognostic model for all-cause and cardiovascular mortality in obesity with MASLD population: Comorbidity insights from triglyceride-glucose and its obesity-related derivatives","name":"articletitle","label":"Article Title"},{"value":"Obesity Research & Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.orcp.2026.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Asia Oceania Association for the Study of Obesity. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}